INTERNATIONAL PATENT: NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM, 国立大学法人東海国立大学機構 FILES APPLICATION FOR "PHARMACEUTICAL FOR ENHANCING THERAPEUTIC EFFECT OF IMMUNE CHECKPOINT INHIBITOR RE-ADMINISTERED TO CANCER PATIENT WHO HAS DISCONTINUED ADMINISTRATION OF IMMUNE CHECKPOINT INHIBITOR"

GENEVA, Feb. 23 -- NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (1, Furo-cho, Chikusa-ku, Nagoya-shi, Aichi4648601), 国立大学法人東海国立大学機構 (愛知県名古屋市千種区不老町１番) filed a patent application (PCT/JP2025/028765) for "PHARMACEUTICAL FOR ENHANCING THERAPEUTIC EFFECT OF IMMUNE CHECKPOINT INHIBITOR RE-ADMINISTERED TO CANCER PATIENT WHO HAS DISCONTINUED ADMINISTRATION OF IMMUNE CHECKPOINT INHIBITOR" on Aug 15, 2025. With publication no. WO/2026/038579, the details related to the patent application was published on Feb 19, ...